Healthcare Services Group (NASDAQ: HCSG) insider transactions
In the twelve months to 10 November 2026, executives and directors of Healthcare Services Group reported 8 open-market sales of 180,799 shares ($3.8m) and 0 open-market purchases, by 5 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 26 October 2026 | Bundick Jason J | EVP/Gen. Counsel/Corp. Secty. | Open-market sale | −18,239 | $25.11 | 17,125 | Form 4 |
| 30 September 2026 | Grant Laura K | Director | Grant or award, 10b5-1 plan | +367 | $20.45 | 18,681 | Form 4 |
| 30 September 2026 | Simmons Kurt JR | Director | Grant or award, 10b5-1 plan | +734 | $20.45 | 31,504 | Form 4 |
| 30 September 2026 | Whalen Thomas Gerard | Director | Grant or award, 10b5-1 plan | +123 | $20.45 | 5,480 | Form 4 |
| 4 August 2026 | Kush Andrew | EVP & Chief Operating Officer | Open-market sale | −15,598 | $23.24 | 22,741 | Form 4 |
| 1 July 2026 | Brophy Andrew M | SVP & Chief Accounting Officer | Grant or award, 10b5-1 plan | +4,381 | — | 19,922 | Form 4 |
| 30 June 2026 | Grant Laura K | Director | Grant or award, 10b5-1 plan | +306 | $24.56 | 18,314 | Form 4 |
| 30 June 2026 | Simmons Kurt JR | Director | Grant or award, 10b5-1 plan | +611 | $24.56 | 30,770 | Form 4 |
| 30 June 2026 | Whalen Thomas Gerard | Director | Grant or award, 10b5-1 plan | +102 | $24.56 | 5,357 | Form 4 |
| 26 May 2026 | Ottaviano Dino D | Director | Grant or award | +1,969 | $20.32 | 15,409 | Form 4 |
| 26 May 2026 | Casey Diane S | Director | Grant or award | +1,969 | $20.32 | 14,975 | Form 4 |
| 26 May 2026 | Visconto Jude | Director | Grant or award | +1,969 | $20.32 | 14,975 | Form 4 |
| 26 May 2026 | Castagnino Daniela | Director | Grant or award | +1,969 | $20.32 | 14,975 | Form 4 |
| 26 May 2026 | Grant Laura K | Director | Grant or award | +1,969 | $20.32 | 18,008 | Form 4 |
| 26 May 2026 | Simmons Kurt JR | Director | Grant or award | +1,969 | $20.32 | 30,159 | Form 4 |
| 26 May 2026 | Whalen Thomas Gerard | Director | Grant or award, 10b5-1 plan | +1,969 | $20.32 | 5,255 | Form 4 |
| 26 May 2026 | Gallagher Thomas Michael | Director | Grant or award | +1,969 | $20.32 | 1,969 | Form 4 |
| 31 March 2026 | Grant Laura K | Director | Grant or award, 10b5-1 plan | +405 | $18.55 | 16,039 | Form 4 |
| 31 March 2026 | Simmons Kurt JR | Director | Grant or award, 10b5-1 plan | +809 | $18.55 | 28,190 | Form 4 |
| 31 March 2026 | Whalen Thomas Gerard | Director | Grant or award, 10b5-1 plan | +135 | $18.55 | 3,286 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Healthcare Services Group page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.